ALGRX 4975 in the Treatment of Patients With Morton's Neuroma
NCT00130962
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuroma
Interventions
DRUG:
ALGRX 4975
Sponsor
AlgoRx Pharmaceuticals